The following information is exclusively reserved for physicians practicing in Austria, the Netherlands, Spain, and Switzerland where the Zio™ monitor ECG monitoring service is currently authorised and made available for use in accordance with local regulatory requirements.

Learn more
Search

Delivering Advanced AI* to Cardiac Monitoring

The iRhythm monitoring service is bringing precision to your practice with our advanced AI Zio™ ECG Utilization Service (ZEUS) System which is CE-marked and FDA cleared. The first deep-learned algorithm clinically proven to be as accurate as cardiologists.1-4

Medical staff on a computer

Enabling patient diagnosis accurately the first time5-7

The iRhythm monitoring service combines up to 14 days of uninterrupted ECG data5-8 with deep-learned AI1-4 that can help to reduce inaccuracies in computerized ECG interpretations and improve the efficiency of expert human ECG interpretation — accurately triaging or prioritizing the most clinically actionable conditions.2

Deep-learned AI platform2

  • Structured in layers to create an artificial neural network
  • Classifies arrhythmias at a high diagnostic performance similar to that of expert cardiologists2

Robust patient analysis

  • Over 10 million patient reports6,9
  • Over 2 billion hours of curated heartbeat data10-11

Specific arrhythmia detection

  • Detects 13 types of arrhythmia classes1-4

Not all medical device AI is created equal

The iRhythm monitoring service is redefining the way cardiac arrhythmias are diagnosed by utilizing the first deep-learned algorithm clinically proven to be as accurate as cardiologists.1-4

Proven precision

The value of the iRhythm monitoring service has been demonstrated in over 100 original scientific research manuscripts.5

EU Zio monitor Sample Report

Advanced AI* with a human touch

Recorded ECG data is processed for detection of arrhythmias using our CE-marked and FDA-cleared, deep-learned algorithm. The data are then curated and verified by Qualified ECG Specialists (QES) to generate a Zio end-of-wear report.1-4 These accurate and succinct reports5 give you data you can trust, so you can make the right diagnosis the first time.5-7

  • Provides comprehensive analysis based on the full wear period8
  • Detects 13 different types of arrhythmias, plus sinus rhythm and artifacts1-4
  • Results in 99% physician agreement6-7,12
View the Zio report

Continue the conversation

The Zio™ service helps you detect arrhythmias earlier, reduce administrative burden, and enhance patient experience — all through a single, streamlined platform.

 

Connect with an iRhythm specialist today to discover how the Zio™ Service can fit into your workflow.

Continue the conversation
Man with child on his shoulders
  1. Data on file. iRhythm Technologies 2020. 
  2. Hannun et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-69. https://doi.org/10.1038/s41591-018-0268-3 
  3. Deep learned algorithm is only available in the United States, European Union, Switzerland, United Kingdom, and Japan.  
  4. FDA 510K clearance, CE mark, UKCA mark, and PMDA-approval.  
  5. Data on file. iRhythm Technologies, 2023. 
  6. Based on the US market data using Zio ECG monitors. 
  7. Zio service provides continuous, uninterrupted recording and a comprehensive end-of-wear report. 
  8. Zio monitor Instructions for Use. iRhythm Technologies, 2023 
  9. Data on file. iRhythm Technologies. 2025. 
  10. Data on file. iRhythm Technologies, 2024. 
  11. Based on the US and UK data using Zio® ECG monitors. 
  12. 99% of physicians agree with the comprehensive end-of-wear report. Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports. Data on file. iRhythm Technologies, 2023.

 

*ZioTM ECG Utilization Service (ZEUS) System

 

The Zio™ service is a long-term continuous ambulatory cardiac monitoring service. It consists of the Zio™ monitor that collects beat-to-beat ECG data and can be worn for up to 14 days; the Zio™ ECG Utilization Service (ZEUS) System deep learned algorithm, which detects arrhythmias. The data is reviewed and curated by a team of Qualified ECG Specialists (QES) to provide the final patient report.

 

For indications for use, warnings & contraindications, visit here.

 

iRhythm, Zio, Zio monitor and ZioSuite are trademarks of iRhythm Technologies, Inc. ©2024 All rights reserved.

 

Zio™ monitor and ZEUS are CE-marked (CE2797).

 

Zio monitor, ZEUS and Zio service are currently available in Austria, Netherlands, Spain & Switzerland.

 

For further regulatory information visit here.

WEB0207.02